Evidence map›Paper›PMID 26452208›Full record

ArticlePLoS genetics2015

A Systems Approach Identifies Essential FOXO3 Functions at Key Steps of Terminal Erythropoiesis.

Raymond Liang, Genís Campreciós, Yan Kou, Kathleen McGrath, Roberta Nowak, Seana Catherman, Carolina L Bigarella, Pauline Rimmelé, Xin Zhang, Merlin Nithya Gnanapragasam and 7 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Molecular and therapeutic frontiers in anemia therapy.The Journal of clinical investigation · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Erythroblast enucleation at a glance.Journal of cell science · 2024
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Metformin as a Fetal Hemoglobin Inducer in Non-transfusion Dependent Thalassemia Patients.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Analyses of erythropoiesis from embryonic stem cell-CD34Journal of cellular and molecular medicine · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Raymond LiangDepartment of Developmental & Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America; Developmental and Stem Cell Biology Multidisciplinary Training Area, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
Genís CampreciósDepartment of Developmental & Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
Yan KouDepartment of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
Kathleen McGrathDepartment of Pediatrics, Center for Pediatric Biomedical Research,University of Rochester Medical Center, Rochester, New York, United States of America.
Roberta NowakDepartment of Cell and Molecular Biology, Scripps Research Institute, La Jolla, California, United States of America.
Seana CathermanDepartment of Pediatrics, Center for Pediatric Biomedical Research,University of Rochester Medical Center, Rochester, New York, United States of America.
Carolina L BigarellaDepartment of Developmental & Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
Pauline RimmeléDepartment of Developmental & Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
Xin ZhangDepartment of Developmental & Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
Merlin Nithya GnanapragasamDepartment of Developmental & Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
James J BiekerDepartment of Developmental & Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America; Developmental and Stem Cell Biology Multidisciplinary Training Area, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
Dmitri PapatsenkoDepartment of Developmental & Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
Avi Ma'ayanDepartment of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
Emery BresnickDepartment of Cell and Regenerative Biology, UW-Madison Blood Research Program, University of Wisconsin, Madison, Wisconsin, United States of America.
Velia FowlerDepartment of Cell and Molecular Biology, Scripps Research Institute, La Jolla, California, United States of America.
James PalisDepartment of Pediatrics, Center for Pediatric Biomedical Research,University of Rochester Medical Center, Rochester, New York, United States of America.
Saghi GhaffariDepartment of Developmental & Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America; Developmental and Stem Cell Biology Multidisciplinary Training Area, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America; Department of Medicine, Division of Hematology, Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
Icahn School of Medicine at Mount Sinai · USUniversity of Rochester Medical Center · USScripps Research Institute · USUniversity of Wisconsin–Madison · US

Funding

THE TISCH CANCER INSTITUTE - CANCER CENTER SUPPORT GRANTP30CA196521 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Deanna L Benson · 2015 to 2026
$35.4M
Data Coordination and Integration Center for LINCS-BD2KU54HL127624 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MA'AYAN, AVI, SCHURER, STEPHAN C · 2014 to 2019
$23.5M
Ontogeny of erythroid lineage differentiationR01DK071116 · NIDDK · UNIVERSITY OF ROCHESTER · PI PALIS, JAMES · 2006 to 2010
$2.2M
AKT Signaling and Oxidative Stress Regulation of ErythropoiesisR01DK077174 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GHAFFARI, SAGHI · 2009 to 2013
$1.9M
Interdisciplinary Training in Systems and Developmental Biology and Birth DefectsT32HD075735 · NICHD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI JABS, ETHYLIN WANG · 2013 to 2022
$1.8M
TRAINING PROGRAM IN CELLULAR AND MOLECULAR BIOLOGYT32GM008553 · NIGMS · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI MLODZIK, MAREK · 1995 to 2012
$1.6M
Novel Determinants of Terminal Erythroid MaturationR01HL116365 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI BRESNICK, EMERY H, GHAFFARI, SAGHI · 2012 to 2015
$1.6M
Intrinsic and extrinsic control of erythropoietic maturationR01DK102260 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BIEKER, JAMES J · 2014 to 2017
$1.5M
NCI NIH HHS P30 CA196521NHLBI NIH HHS R01 HL116365NHLBI NIH HHS U54 HL127624NICHD NIH HHS T32 HD075735NIDDK NIH HHS R01 DK071116NIDDK NIH HHS R01 DK077174NIDDK NIH HHS R01 DK102260NIGMS NIH HHS T32 GM008553NIGMS NIH HHS T32 GM08553-13
6 · The paper itself

Abstract

Circulating red blood cells (RBCs) are essential for tissue oxygenation and homeostasis. Defective terminal erythropoiesis contributes to decreased generation of RBCs in many disorders. Specifically, ineffective nuclear expulsion (enucleation) during terminal maturation is an obstacle to therapeutic RBC production in vitro. To obtain mechanistic insights into terminal erythropoiesis we focused on FOXO3, a transcription factor implicated in erythroid disorders. Using an integrated computational and experimental systems biology approach, we show that FOXO3 is essential for the correct temporal gene expression during terminal erythropoiesis. We demonstrate that the FOXO3-dependent genetic network has critical physiological functions at key steps of terminal erythropoiesis including enucleation and mitochondrial clearance processes. FOXO3 loss deregulated transcription of genes implicated in cell polarity, nucleosome assembly and DNA packaging-related processes and compromised erythroid enucleation. Using high-resolution confocal microscopy and imaging flow cytometry we show that cell polarization is impaired leading to multilobulated Foxo3-/- erythroblasts defective in nuclear expulsion. Ectopic FOXO3 expression rescued Foxo3-/- erythroblast enucleation-related gene transcription, enucleation defects and terminal maturation. Remarkably, FOXO3 ectopic expression increased wild type erythroblast maturation and enucleation suggesting that enhancing FOXO3 activity may improve RBCs production. Altogether these studies uncover FOXO3 as a novel regulator of erythroblast enucleation and terminal maturation suggesting FOXO3 modulation might be therapeutic in disorders with defective erythroid maturation.

Indexed as

Systems BiologyAnimalsAutophagyBone Marrow CellsCell PolarityErythroblastsErythrocytesErythropoiesisFlow CytometryForkhead Box Protein O3Forkhead Transcription FactorsGene Expression Regulation, DevelopmentalGene Regulatory NetworksHomeostasisHumansMiceForkhead Box Protein O3Forkhead Transcription FactorsFoxO3 protein, mouse

Identifiers

PMID26452208
PMCPMC4599908
OpenAlexW2174761822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.